'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Entero Healthcare Solutions Limited
ENTERO (NSE) · ENTERO (BSE 544122) · ISIN INE010601016 · Pharmacy Retail · Est. 2018 · listed 2024 · website
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹83.27 cr and profit after tax ₹3.46 cr. Revenue was 4.9% higher than in Q1 FY26.
Next: Board meeting: financial results on 4 November 2026.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹83.27 cr | ₹3.46 cr | 0.79 | 7 Aug 2026 |
| Q4 FY26 standalone | ₹78.93 cr | ₹13.42 cr | 3.08 | 25 May 2026 |
| Q3 FY26 standalone | ₹106.74 cr | ₹0.81 cr | 0.18 | 12 Feb 2026 |
| Q2 FY26 standalone | ₹83.22 cr | ₹5.7 cr | 1.31 | 12 Nov 2025 |
| Q1 FY26 standalone | ₹79.35 cr | ₹6.96 cr | 1.60 | 8 Aug 2025 |
| Q4 FY25 standalone | ₹72.3 cr | −₹27.81 cr | −6.39 | 5 Oct 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹1,683.04 cr | ₹107.68 cr | ₹2,157.66 cr |
| 30 Sep 2025 standalone | ₹1,670.16 cr | ₹0 cr | ₹1,826.66 cr |
| 31 Mar 2025 standalone | ₹1,650.38 cr | ₹0 cr | ₹1,803.53 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 52.40% | 5.77% | 21.16% | 47.60% |
Latest filings
- Entero Healthcare Solutions Limited has informed the Exchange about Transcript 17 August 2026 · NSE
- Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording on Unaudited Financial Results of the Company for the quarter ended June 30, 2026 10 August 2026 · NSE
- Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation 7 August 2026 · NSE
- Annual Report FY2025-26 (New) 27 July 2026 · NSE
- Entero Healthcare Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 26, 2026. 26 June 2026 · NSE
Other companies in Pharmacy Retail
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 5 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.